Created by: Hellenbrecht (ELIC) , generated 2006/03/14, last changed: 2011/09/13

Original list of contact persons

 

Name	Initials	E-mail	Clinic	Country
Lead Participants
J. Apperley *	APP		Imperial College	UK
A. Gratwohl	GRA		University of Basel/University Hospitals	Switzerland
D. Niederwieser	NIED		Universität Leipzig	Germany
Participants
M. Baccarani	BAC		Universitá di Bologna- Unita Complessa di Istituti di Cardiologia ed Ematologia	Italy
A. Bacigalupo	BACI		Azienda Ospedaliera - Ospedale San Martino	Italy
N. Blijlevens *	BLIJ		Stichting Katholieke Universiteit, University Medical Centre Nijmegen	Netherlands
R. Brand	BRA		52 Leiden University Medical Center	Netherlands
M. Brune *	BRU		Göteborg University	Sweden
A. Burnett	BUR		Cardiff University	UK
T. de Witte	DEW		Stichting Katholieke Universiteit, University Medical Centre	Netherlands
P. Dreger	DRE		Universitätsklinikum Heidelberg	Germany
F. Frassoni	FRA		Azienda Ospedaliera Ospedale San Martino	Italy
G. Gahrton *	GAH		Karolinska Institutet	Sweden
E. Gluckman *	GLU		Association pour la Recherche sur les Transplantations Medullaires	France
H. Greinix *	GREI		Medizinische Universität Wien	Austria
C. Guglielmi	GUG		Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi di Roma "La Sapienza"	Italy
J. Hasford	HAS		Institut für Medizinische Informationsverarbeitung,Biometrie und Epidemologie (IBE)	Germany
A. Ho	AHO		Ruprecht-Karls-Universität	Germany
J. Holowiecki	HOLO		Medical University of Silesia	Poland
H.J. Kolb	KOL		Ludwig-Maximilians-Universität	Germany
B. Labar	LAB		University Hospital Center	Croatia
P. Ljungman	LJU		Karolinska Hospital and Institutet	Sweden
B. Löwenberg	LOE		Erasmus University Medical Center Rotterdam	Netherlands
F. MacDonald *	MCD		Hospital Clinic Provincial de Barcelona	Spain
J. Mayer			Fakultni nemocnice	Czech Republic
V. Rocha	ROC		Institut Univ. d`Hematologie Hopital St. Louis	France
J.M. Rowe	ROW		Fund for Medical Research Development of Infrastructure and Health Services, Rambam Medical Center	Israel
T. Ruutu	RUU		Helsinki University Central Hospital	Finland
S. Schönland	SCHOE		University Clinic of Heidelberg	Germany
J. Sierra	SIE		Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Spain
B. Simonsson	SIM		Uppsala Universitet	Sweden
A. Urbano-Ispizua	URB		Hospital Clinic Provincial de Barcelona	Spain
* = Female Researcher

Lead Participants:

Prof.Dr. J. Apperley (London, UK): Particular interests are the biology and management of CML which has led naturally to an extensive experience in autologous and allogeneic stem cell transplantation. She is currently president of both the European and British Societies of Blood and Marrow Transplantation (BSBMT and EBMT), having previously served on the board of both organisations as the chair of the Chronic Leukemia Working Party of the EBMT and the Chair of the Clinical Trials Committee of the BSBMT. She is also on the Executive Committee of IBMTR. She is a past Chair of the Clinical Working Group of World Marrow Donor Association (WMDA).

Prof.Dr. A. Gratwohl (Basel, Switzerland): Longstanding experience in clinical and experimental hematopoetic stem cell transplantation (HSCT). Former President of EBMT and current director of the EBMT activity survey. Member of the Acute and Chronic Leukemia Working Party of EBMT. Board member of EHA. Chair or Co-chair of several prospective randomized studies in the field of HSCT; defining the role of peripheral blood versus bone marrow as stem cell source; assessment of main pre-, peri- and post-transplant risk factors, with a particular interest in Graft-versus-host Disease (GvHD). Responsible for co-ordinating retrospective risk factor analyses and prospective studies. Director of the EBMT activity surveys on incidence of HSCT in Europe and trend analyses.

Prof.Dr. D. Niederwieser (Leipzig, Germany): Longstanding experience in clinical and experimental HSCT. Former President of the Austrian Society of Transplantation – Austrotransplant. Chairman of the Chronic Leukemia Working Party of EBMT. Member of the Acute and Chronic Leukemia WP of EBMT. PI or Co-PI of prospective randomised studies in the field of HSCT and in hematology; special interests in allogeneic stem cell transplantation with reduced conditioning. Reviewer for journals in the field of HSCT. Co-prinicipal investigator of the German AML Intergroup Study of the German Leukemia Network.

Participants:

Prof.Dr. M. Baccarani (Bologna, Italy):

Prof.Dr. A. Bacigalupo (San Martino, Italy): Head of the Department of Hematology at Ospedale San Martino. 1973 he started an allogeneic transplant programme and has performed with his team over 1300 allogeneic bone marrow transplants. He has conducted numerous clinical trials in patients with aplastic anaemia, focussing particularly on graft-versus-host and graft-versus-leukemia effects of allogeneic transplantation. Board member of the European Group for Blood and Marrow Transplantation (EBMT) since 1983 and was elected as EBMT President for the 1998-2002 term. President of the Italian Group of Bone Marrow Transplantation. Research interests include bone marrow transplantation, graft-versus-host disease, graft-versus-leukemia, viral infection, leukemia and aplastic anaemia.

Dr. N. Blijlevens (Nijmegen, Netherlands):

Dr. R. Brand (Leiden, Netherlands): Department of Medical Statistics, University of Leiden; Director EBMT European Support Office. Longstanding interest in and experience in conducting, analysing and reporting prospective and retrospective dataanlyses. Expert in Quality control schemes. Developper and introducer of an Internet based complex data capture, data reporting system PROMISE.

Prof.Dr. M. Brune (Göteborg, Sweden): Associated Professor of Hematology, Faculty of Medicine, Göteborg University. Medical Director, Center for Hematopoietic Cell Transplantation, Sahlgrenska University Hospital and Queen Silvia Children´s Hospital, Göteborg. Particular scientific interest in immunotherapy and the use of reduced intensity conditioning in the setting of allogeneic stem cell transplantation.

Prof.Dr. A. Burnett (Cardiff, UK):

Prof.Dr. T. de Witte (Nijmegen, Netherlands):

P. Dreger (Heidelberg, Germany):

Dr. F. Frassoni (Genova, Italy):

Prof.Dr. G. Gahrton (Stockholm, Sweden): Professor at the Karolinska Institutet and Consultant at the Departments of Medicine and Hematology, Huddinge University Hospital, Stockholm. Longstanding experience in clinical and experimental hematology and stem cell transplantation. Previously Head of the Department of Medicine, the Karolinska Institutet at Huddinge University Hospital and Chairman of the Nobel Committee of the Karolinska Institutet. Previously President of the European Group for Blood and Marrow Transplantation (EBMT) and President of the World Marrow Donor Association (WMDA). Presently Chairman of the Myeloma Subcommittee of the EBMT and Chairman of the Swedish Society of Gene Therapy.

Prof.Dr. E. Gluckman (Paris, France): Chair of the Bone Marrow Transplant Unit, Hopital Saint-Louis, Paris. Director of Laboratory of Biology of hematopoietic stem cells, Paris University. Medical coordinator of the Department Hematology Oncology, Hospital Saint Louis. Founding member and former President of the European Blood and Marrow Transplant Group. President of the Board of Immunobiology working Party of the EBMT, Project Leader of the Eurocord Transplant concerted action, Board of the Structure and Strength Committee of Hôpital Saint-Louis, Board of the Organisation Committee of ESH (European School of Hematology), Main Investigator Eurocord II Biomed II, Associated Investigator Eurobank Biomed II, Netcord member. Organisor of the post graduate course of the ESH and EBMT. Chevalier de la Légion d’Honneur, Officier de l’Ordre du Mérite, Fellow of the Royal Academy of Pathology FRCP, Prize of the French Academy of Medicine, Ham-Wasserman award of the American Society of Hematology. Main research interests: allogeneic hematopoietic stem cell transplantation, aplastic anemia, Fanconi anemia, cord blood biology and transplant.

Prof.Dr. H. Greinix (Vienna, Austria): Experience in clinical hematopoietic stem cell transplantation. Member of the European Group for Blood and Marrow transplantation, World Marrow Donnor Association and ethic commission. Head of the stem cell working group of the Austrian Society of Hematology and Oncology, Austrian representative of the JACIE-Subcommittee and member of the board of the World Marrow Donor Association.

Dr. C. Guglielmi (Rome, Italy): Division of Hematology, University “La Sapienza” of Roma, II Faculty of Medicine, Roma. Longstanding experience in clinical and experimental hematology and stem cell transplantation (HSCT). Member of the Chronic Leukemia WP of EBMT, Relapse sub-committee chair. Chair or Co-chair of several retrospective and prospective studies in the field of malignant diseases and HSCT; defining the role of autologous stem cell transplant in relapsed aggressive lymphomas, assessment of main prognostic factors in diffuse large cell lymphoma at first relapse, risk factors for survival in chronic myelogenous leukemia (CML) relapsing after allogeneic HSCT, relevance of initial cell dose in CML treated with donor lymphocyte infusions, prognostic relevance of GvHD in CML.

Prof.Dr. J. Hasford (München, Germany):

Prof.Dr. A. Ho (Heidelberg, Germany): Chair, Department of Medicine V, University of Heidelberg, Germany. University of Heidelberg, University of Ottawa, Canada (1990 - 1992), Co-Division Chief, Division of Hematology-Oncology, Director, Bone Marrow Transplantation Program, San Diego, USA (1992 - 1998), Consultant, Division of Grant Reviews, NIH, USA (1994 - 1998). Appointed to “Central Ethics Committee for Stem Cell Research“, German Parliament (2002 - present).

Prof.Dr. J. Holowiecki (Katowice, Poland):

Prof.Dr. H.J. Kolb (Munich, Germany): Head of Hematopoietic Cell Transplantation; Dept. of Medicine III, Klinkum University of Munich and GSF-National Research Center for Envirement and Health; Expert in stem cell transplantation. T-cell depeletion, cytokines and microangiopathy. Radiation biology, adoptive immunotherapy with donor lymphocytes.

Prof.Dr. B. Labar (Zagreb, Croatia):

Prof.Dr. P. Ljungman (Stockholm, Sweden):

Prof.Dr. B. Löwenberg (Rotterdam, Netherlands):

F. MacDonald (Barcelona, Spain):

Prof.Dr. J. Mayer (Brno, Czech Republic):

Dr. V. Rocha (Paris, France):

Prof.Dr. J.M. Rowe (Haifa, Israel):

Prof.Dr. T. Ruutu (Helsinki, Finland):

S. Schönland (Heidelberg, Germany):

J. Sierra (Barcelona, Spain):

Prof.Dr. B. Simonsson (Uppsala, Sweden):

Dr. A. Urbano-Ispizua (Barcelona, Spain): Consultant, Department of Hematology, Hospital Clinic of Barcelona. During the last 10 years staff member of the bone marrow transplant unit of the Hospital Clinic of Barcelona, where more than 1,000 transplantations have been performed over the last 20 years. Founder of the Spanish Group of Allogeneic Peripheral Blood Transplantation. He is particularly interested in the use of allogeneic peripheral blood transplantation and in the study of the clinical consequences of graft manipulation. Current Secretary of the EBMT group. Within this organisation, he is working in setting up a common European Accreditation program for transplant procedures. Executive Officer of JACIE.